GDF-8 calculator
The scientific name for myostatin — the body's natural brake on muscle growth. Note: myostatin inhibitors are what's studied, not myostatin itself.
Also known as: Myostatin, Growth Differentiation Factor 8
FDA status — not an approved drug Not FDA-approved for any use. GDF-8 is myostatin itself, which limits muscle growth; therapeutic interest is in blocking it, not administering it. There is no approved product.
Schedule GDF-8 → Set your dosing schedule and get a phone notification when each dose is due. Free.
What GDF-8 is
GDF-8 is the scientific name for myostatin, a protein that acts as the body's natural brake on muscle growth. It is important to understand that myostatin itself is not a therapeutic target to administer — the entire field of interest is in blocking it. Animals lacking myostatin develop dramatically increased muscle mass.
Research depth: 1/5 Well-characterized biology as the muscle brake; therapeutic interest is in blocking it, not administering it. Human trials: Not applicable. This measures how much has been studied — counting animal and laboratory work — not whether it works for you.
How GDF-8 works
Myostatin is a TGF-beta-family protein that signals muscle cells to limit their growth, keeping muscle mass within normal bounds. When myostatin is absent or blocked, this brake is released and muscle grows excessively — the dramatic 'double-muscled' effect seen in animals lacking the gene. This is why myostatin inhibitors, not myostatin, are studied for muscle-wasting diseases.
GDF-8 side effects
Commonly reported
- Not administered as a therapeutic
- Interest is in inhibitors, not the protein itself
Serious — seek medical care
- No therapeutic use — it is the target, not the treatment
- Blocking myostatin (the actual goal) carries its own unstudied risks
- Products claiming to be 'GDF-8' for muscle building are mislabeled or fraudulent
This list is not exhaustive. Report anything unexpected to the clinician who prescribed it. If you have severe abdominal pain, trouble breathing, or signs of an allergic reaction, seek care the same day. See also our guide to peptide side effects by class.
A worked example
A 1 mg vial reconstituted with 2 mL of bacteriostatic water gives 0.5 mg/mL. A 500 mcg dose is then 1 mL — about 100 units on a 100-unit insulin syringe, giving roughly 2 doses per vial before accounting for residual volume left in the vial and syringe.
Prefer paper? Download the printable GDF-8 dosing chart (PDF) — every vial size and water volume in syringe units, with the same review byline as this page. All charts →
Commonly cited dose range
Figures circulating for GDF-8 run from 100 mcg to 1000 mcg. There is no dosing for GDF-8 itself — it is the target that inhibitors act against, not a therapeutic. Figures shown are reference points only. Therapeutic interest is in myostatin inhibitors.
Read this as reference information, not instruction. These numbers describe what is commonly discussed, not what is right for any individual. Dose, frequency, and whether to use GDF-8 at all are decisions for a licensed clinician who knows your history.
Common questions
Why would anyone take myostatin (GDF-8)?
They wouldn't — myostatin limits muscle growth, so the therapeutic interest is entirely in blocking it. Animals engineered to lack myostatin develop enormous muscle mass, which is why myostatin inhibitors are studied for muscle-wasting conditions.
What is GDF-8's role in the body?
GDF-8 (myostatin) is a natural brake on muscle growth, preventing muscles from growing excessively. Blocking it releases that brake, which is the basis for the myostatin-inhibitor drugs in development.